Candriam SCA’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.37M | Buy |
12,046
+728
| +6% | +$191K | 0.02% | 444 |
|
|
2026
Q1 | $3.02M | Buy |
11,318
+113
| +1% | +$30.6K | 0.02% | 456 |
|
|
2025
Q4 | $2.81M | Sell |
11,205
-35,461
| -76% | -$9.42M | 0.01% | 453 |
|
|
2025
Q3 | $13.4M | Sell |
46,666
-30,172
| -39% | -$8.08M | 0.07% | 231 |
|
|
2025
Q2 | $20.2M | Sell |
76,838
-262
| -0.3% | -$63.8K | 0.12% | 163 |
|
|
2025
Q1 | $17.9M | Buy |
77,100
+63,931
| +485% | +$15.5M | 0.11% | 171 |
|
|
2024
Q4 | $3.02M | Buy |
13,169
+1,901
| +17% | +$436K | 0.02% | 437 |
|
|
2024
Q3 | $2.52M | Sell |
11,268
-45,015
| -80% | -$9.89M | 0.01% | 470 |
|
|
2024
Q2 | $11.5M | Buy |
56,283
+2,558
| +5% | +$520K | 0.07% | 239 |
|
|
2024
Q1 | $11.7M | Buy |
53,725
+32,083
| +148% | +$7.07M | 0.08% | 241 |
|
|
2023
Q4 | $4.92M | Buy |
21,642
+2,708
| +14% | +$569K | 0.03% | 337 |
|
|
2023
Q3 | $3.81M | Sell |
18,934
-2,985
| -14% | -$630K | 0.03% | 339 |
|
|
2023
Q2 | $4.54M | Sell |
21,919
-19,764
| -47% | -$3.83M | 0.03% | 351 |
|
|
2023
Q1 | $7.56M | Sell |
41,683
-15,360
| -27% | -$3.16M | 0.05% | 299 |
|
|
2022
Q4 | $11.5M | Sell |
57,043
-9,783
| -15% | -$1.91M | 0.08% | 243 |
|
|
2022
Q3 | $11.8M | Buy |
66,826
+16,114
| +32% | +$3.3M | 0.08% | 234 |
|
|
2022
Q2 | $10.2M | Sell |
50,712
-21,251
| -30% | -$4.53M | 0.08% | 222 |
|
|
2022
Q1 | $16.3M | Buy |
71,963
+7,356
| +11% | +$1.73M | 0.11% | 192 |
|
|
2021
Q4 | $17.4M | Buy |
64,607
+4,434
| +7% | +$1.1M | 0.11% | 192 |
|
|
2021
Q3 | $14.5M | Buy |
60,173
+7,624
| +15% | +$1.92M | 0.1% | 219 |
|
|
2021
Q2 | $12.5M | Sell |
52,549
-192,177
| -79% | -$43.8M | 0.09% | 258 |
|
|
2021
Q1 | $41.1M | Sell |
244,726
-6
| -0% | -$1.2K | 0.34% | 69 |
|
|
2020
Q4 | $42.8M | Sell |
244,732
-9,202
| -4% | -$1.59M | 0.34% | 69 |
|
|
2020
Q3 | $41.1M | Buy |
253,934
+12,149
| +5% | +$1.93M | 0.39% | 54 |
|
|
2020
Q2 | $34.5M | Buy |
241,785
+105,844
| +78% | +$14.6M | 0.36% | 62 |
|
|
2020
Q1 | $19.3M | Buy |
135,941
+17
| +0% | +$2.45K | 0.21% | 106 |
|
|
2019
Q4 | $19.8M | Buy |
135,924
+13,986
| +11% | +$2.02M | 0.21% | 106 |
|
|
2019
Q3 | $17.6M | Sell |
121,938
-3,120
| -2% | -$455K | 0.23% | 92 |
|
|
2019
Q2 | $18.5M | Buy |
125,058
+12,205
| +11% | +$1.7M | 0.23% | 99 |
|
|
2019
Q1 | $14.8M | Buy |
112,853
+84,976
| +305% | +$10.5M | 0.19% | 119 |
|
|
2018
Q4 | $3.03M | Buy |
27,877
+890
| +3% | +$119K | 0.05% | 373 |
|
|
2018
Q3 | $4.03M | Sell |
26,987
-4,839
| -15% | -$736K | 0.05% | 369 |
|
|
2018
Q2 | $4.91M | Sell |
31,826
-18
| -0.1% | -$2.72K | 0.08% | 301 |
|
|
2018
Q1 | $4.42M | Buy |
31,844
+5,481
| +21% | +$805K | 0.08% | 304 |
|
|
2017
Q4 | $3.61M | Sell |
26,363
-879
| -3% | -$116K | 0.06% | 331 |
|
|
2017
Q3 | $3.53M | Sell |
27,242
-2,612
| -9% | -$348K | 0.06% | 342 |
|
|
2017
Q2 | $3.95M | Buy |
29,854
+493
| +2% | +$60.4K | 0.07% | 314 |
|
|
2017
Q1 | $3.62M | Sell |
29,361
-10,157
| -26% | -$1.2M | 0.07% | 329 |
|
|
2016
Q4 | $4.36M | Buy |
39,518
+10,760
| +37% | +$1.2M | 0.1% | 233 |
|
|
2016
Q3 | $3.4M | Buy |
28,758
+23,059
| +405% | +$2.72M | 0.08% | 260 |
|
|
2016
Q2 | $638K | Sell |
5,699
-20,228
| -78% | -$2.18M | 0.02% | 524 |
|
|
2016
Q1 | $2.6M | Buy |
25,927
+9,309
| +56% | +$893K | 0.06% | 284 |
|
|
2015
Q4 | $1.76M | Sell |
16,618
-116,019
| -87% | -$12M | 0.05% | 317 |
|
|
2015
Q3 | $12.4M | Buy |
132,637
+117,573
| +780% | +$12.2M | 0.3% | 95 |
|
|
2015
Q2 | $1.57M | Sell |
15,064
-2,910
| -16% | -$303K | 0.03% | 394 |
|
|
2015
Q1 | $1.95M | Sell |
17,974
-58,800
| -77% | -$6.05M | 0.04% | 391 |
|
|
2014
Q4 | $7.12M | Buy |
+76,774
| New | +$6.78M | 0.15% | 190 |
|
Other funds holding LH
Candriam SCA's LH Position: Q2 2026 in Review
Candriam SCA increased its Labcorp (LH) stake by 6.4% in Q2 2026, buying an estimated $191K and bringing the position to 12,046 shares worth $3.37M. The position accounts for 0.02% of the portfolio, ranked #444.
Candriam SCA first reported a position in LH in Q4 2014 and has held it in 47 quarters since. The position peaked at $42.8M in Q4 2020. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Candriam SCA held 12,046 shares of Labcorp worth $3.37M as of Q2 2026.
- Candriam SCA bought 728 Labcorp shares in Q2 2026, an estimated $191K.
- Labcorp made up 0.02% of Candriam SCA's portfolio in Q2 2026, its #444 holding.
- Candriam SCA first reported a position in Labcorp in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Labcorp position peaked at $42.8M in Q4 2020.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.